Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-24-138766
Filing Date
2024-12-20
Accepted
2024-12-20 06:56:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 424b5_engene_pro_supp_at.htm 424B5 529723
2 GRAPHIC img211581587_0.jpg GRAPHIC 87857
3 GRAPHIC img211581587_1.jpg GRAPHIC 15435
  Complete submission text file 0000950170-24-138766.txt   673043
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 424B5 | Act: 33 | File No.: 333-283201 | Film No.: 241565080
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)